China's pharma industry is a risk to domestic (US) suppliers

…In addition, by manufacturing in China, drug companies avoid FDA regulations and inspections; enjoy low prices; and turn a blind eye to potentially contaminated, low-potency, or counterfeit medicines. The FDA has failed to require inspections of drug-making plants in China, and pharmaceutical companies utilizing Chinese plants do so at their discretion. In China, as in many countries outside the U.S., safe drug-production procedures, quality testing, and expiration dating and labeling requirements are ignored. In this way, counterfeit and unapproved drugs can be sent to legitimate manufacturers and used to produce legitimate drugs. Chinese companies have provided false documents and refused to submit to audits.

https://www.americanthinker.com/articles/2019/01/exposing_the_risks_of_americas_dependence_on_china_for_medicine.html